Mirtazapine
Product Images NDC 68071-2884

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 68071-2884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2884 9)

Pdp (68071 2884 9)
Label for Mirtazapine 30mg tablets by NuCare Pharmaceuticals, Inc. Displays product NDC 68071-2884-9 and states 90 tablets. Describes the tablet as capsule-shaped, reddish brown, biconvex with score line between '0' and '9' on one side and 'A' debossed on the other. Includes storage instructions and standard warnings.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Mirtazpine Structure (Mirtazapine Str)
Chemical structure of the active ingredient Mirtazapine, showing its fused ring system including a piperazine and pyridine ring with a methyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.